Form 4 for DGX Quest Diagnostics
Accepted 2025-04-04 00:00:00 ET · period of report 2025-04-02 · accession 0001022079-25-000107 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-04-04 | 2025-04-02 | DGX | KUPPUSAMY KARTHIK | SVP, Clinical Solutions | S - Sale | $170.00 | -2,555 | 10.6K | -19% | -$434.4K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-04-02 | S | D | 2,555 | $170.00 | 10,575 | D | — | — | (F2) The amount includes exempt purchases made under the Company's stock purchase plan since the date of the reporting person's last filing on Form 4. |